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A B S T R A C T
A mathematical model for the transmission dynamics of the 2009 A/H1N1 inﬂuenza epidemic in the Republic
of Korea is developed. The simulation period is separated into three consecutive periods based on the
government's intervention strategies: the nonpharmaceutical strategy is used during Period 1. The nonphar-
maceutical and antiviral strategies are executed during Period 2 and the vaccine strategy is added during Period
3. During Period 1, we estimate the reduction in the transmission rate due to the government's intervention
policies as a diﬀerence between the data-ﬁtted and uncontrolled transmission rate that is derived from the basic
reproductive number, R0, of the model without intervention. This quantiﬁed reduced transmission rate is used
as an upperbound of the nonpharmaceutical control for studying optimal control strategies, which is a new
approach for determining the realistic upperbound of control. In this study, we also explore the real-time
prediction of incidence using the mathematical model during the early stage of the epidemic. We investigate the
impact of vaccination coverage and timing with respect to the cumulative incidence. The result implies that early
vaccination plays a signiﬁcant role for preventing the epidemic.
1. Introduction
During the spring of 2009, the A/H1N1 inﬂuenza virus spread
rapidly across the globe. As of August 2010, more than 214 countries
reported conﬁrmed cases, including over 18,449 deaths (World Health
Organization, 2010a,b). The total number of patients of the 2009 A/
H1N1 inﬂuenza is estimated to be in the range of tens of millions to
200 million (World Health Organization Director-General, 2011).
Owing to the mild symptoms and low fatality rate, the 2009 A/H1N1
inﬂuenza generated numerous patients throughout the world. Although
2009 A/H1N1 virus that caused the pandemic is now a regular human
ﬂu virus and continues seasonally worldwide (Centers for Disease
Control and Prevention, 2010), scientists have been warning that
another inﬂuenza pandemic could strike at any moment (Enserink
and Cohen, 2009). Based on past pandemics, the preparedness and
response of public health care for an inﬂuenza pandemic crisis must be
improved. For eﬀective epidemic disease preparedness, it is necessary
not only to analyze control strategies on the 2009 A/H1N1 inﬂuenza
epidemic, but also to establish a new and improved public health care
system.
Mathematical modeling is a good tool for analyzing the past
intervention strategies and identifying promising new ones. In parti-
cular, mathematical modeling quantiﬁes the beneﬁts of abstract and
diverse government intervention strategies. Many researchers have
devoted their eﬀort to the study of mathematical modeling and
intervention strategies for inﬂuenza epidemics. Arino et al. (2006)
and Arino et al. (2008) considered asymptomatic individuals in the
formulation of the Susceptible-Latent-Infected-Asymptomatic-
Recovered (SLIAR) model to describe an inﬂuenza pandemic, and
the basic reproductive number and the ﬁnal epidemic size were
analyzed. The intervention eﬀects with limited antiviral and isolation
controls, based on the seven compartment model, were studied by Lee
et al. (2010) and it was established that isolation plays an important
role especially when antiviral intervention is limited. Chowell et al.
(2009) developed a nine compartments model with six age groups and
suggested a vaccination strategy for Mexico. Towers and Feng (2009)
predicted the A/H1N1 inﬂuenza pandemic and assessed the Centers for
Disease Control and Prevention (CDC) vaccination campaign using
their seasonal SIR model. Qiu and Feng (2010) developed a mathe-
matical model for inﬂuenza that considered the drug-sensitive and
resistant strains to examine the eﬀect of intervention through antiviral
and vaccination strategies. A simple SAIR model for A/H1N1 inﬂuenza
and a complex model for considering co-infection of A/H1N1 inﬂuenza
and seasonal ﬂu were studied by Prosper et al. (2011). Optimal control
strategies were also suggested in their study. Lee et al. (2012)
formulated an age-structured model with age-speciﬁc control functions
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and suggested optimal vaccination strategies. Tchuenche et al. (2011)
developed a mathematical model with three control functions, vaccine
waning, vaccine eﬀectiveness, and treatment eﬀectiveness controls and
carried out a sensitivity analysis to determine the important factors of
the disease transmission and prevalence. Lee et al. (2013b) studied a
seasonal forcing model and an age-structured model and investigated
the optimal intervention strategies for inﬂuenza outbreaks.
Our work is distinguished from previous works by its use of data on
the 2009 A/H1N1 inﬂuenza in the Republic of Korea. Using a
parameter estimation process, the government's intervention strategies
conducted in 2009 are quantiﬁed. Moreover, the quantiﬁed values are
used as the upperbounds of the optimal control functions, a key idea in
optimal control theory. This approach leads to realistic and eﬀective
intervention strategies. Using a simple epidemic model without optimal
control, we also explore the real-time prediction of the 2009 A/H1N1
inﬂuenza epidemic in the Republic of Korea in the early spread. It is
possible to use this model as a comparative tool for government
intervention strategies. To prevent an inﬂuenza epidemic, the timing
and amount of vaccine are the most critical issues. In our study, we
introduce the optimal control theory to analyze and propose optimal
vaccine strategies. Furthermore, the early optimal vaccine strategies
with the limited vaccination coverages are discussed.
The remainder of this paper is organized as follows. Section 2
describes the mathematical modeling of A/H1N1 inﬂuenza in the
Republic of Korea. Parameter estimation and the bootstrap method
are discussed in this section. In Section 3, an optimal control frame-
work is presented. We present the real-time prediction of A/H1N1
incidence and suggest optimal intervention strategies in Section 4.
Conclusions are presented in the ﬁnal section.
2. Materials and methods
2.1. Epidemic data
The Korea Centers for Disease Control and Prevention (KCDC)
intensiﬁed the national public health crisis phase from Attention to
Caution on April 27, 2009 after the ﬁrst detection of an A/H1N1
patient in the Republic of Korea (Lee et al., 2013a). The government
then implemented various control policies. Owing to the well-struc-
tured public health care system in the Republic of Korea, most
inﬂuenza patients went to hospitals, and it was mandatory for doctors
to report inﬂuenza patients to the KCDC (Park and Cho, 2014). This
system improved the reliability of the inﬂuenza data collected by the
Korean government.
Fig. 1 shows the number of daily incidence data in the Republic of
Korea from April 27 to December 31, 2009. At the beginning of the
epidemic, only cases conﬁrmed by polymerase chain reaction (PCR)
among the inﬂuenza like illnesses (ILIs) were reported to the KCDC
and it took 3–5 days to obtain the PCR result. As the epidemic
progressed, the number of ILI patients increased rapidly. On August
20, 2009, the KCDC changed the guideline of the antiviral prescription
and the reporting system so that doctors could prescribe antiviral drugs
to the ILI patients without a PCR test and were instructed to report the
cases who prescribed the antiviral drugs. Therefore, the incidence data
indicates that the PCR conﬁrmed cases during Period 1 (April 27–
August 19), while the incidence data during Period 2 (August 20–
October 14) and Period 3 (October 15–December 31) include all the
people who were prescribed antiviral drugs.
The government focused on nonpharmaceutical intervention stra-
tegies such as quarantine and isolation of patients during Period 1. As
of August 20, the antiviral intervention strategy was implemented more
actively. During Period 2, both nonpharmaceutical and antiviral
intervention strategies were conducted. About six months after the
outbreak onset, the vaccine was approved and the vaccination started.
The vaccine strategy was added during Period 3. Table 1 lists the
separate time periods and the corresponding policies conducted by the
Korean government in 2009.
2.2. SEIAR inﬂuenza model
Before we present a model of the 2009 A/H1N1 inﬂuenza in the
Republic of Korea, a SEIAR inﬂuenza model without interventions
(uncontrolled model) is described in this subsection. The total popula-
tion (N) is classiﬁed into ﬁve subclasses: susceptible (S), latent (E),
symptomatic infectious (I), asymptomatic infectious (A), and recovered
(R) individuals. The SEIAR model is governed by nonlinear diﬀerential
equations as follows:
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where Λ E qI δA= ϵ + + .
Since the duration of an inﬂuenza epidemic is relatively short, the
demographic eﬀect is neglected. The parameter β* denotes the
transmission rate without interventions at which a susceptible indivi-
dual is infected and becomes a latent individual. Note that A/H1N1
inﬂuenza can be spread by latent and asymptomatic individuals as well
as symptomatic individuals. We set the following infectivity reduction
factors: ϵ for latency, q for symptomatic, and δ for asymptomatic
individuals ( q δ0 ≤ ϵ, , ≤ 1). The parameter κ is the progression rate to
infectious individuals; therefore, κ1/ implies the average latent period.
The constant p represents the fraction of latent individuals developing
symptoms ( p0 ≤ ≤ 1). The parameters α and η are the recovery rates of
infectious and asymptomatic groups, respectively. Since the fatality
rate of the 2009 A/H1N1 inﬂuenza in the Republic of Korea is
estimated to be 16 per 100,000 cases (Kim et al., 2011), the fatality
rate is ignored in our study.
Fig. 1. The 2009 A/H1N1 inﬂuenza incidence from April 27 to December 31 in the
Republic of Korea.
Table 1
Three consecutive periods and the corresponding intervention polices.
Intervention policy Period 1 (April
27–August 19)
Period 2 (August
20–October 18)
Period 3 (October
19–December 31)
Nonpharmaceutical ◯ ◯ ◯
Antiviral ◯ ◯
Vaccine ◯
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The basic reproductive number, R0, is the number of secondary
cases generated by a primary patient over the infectious period in a
susceptible population. In general, R0 depends on the infectious period,
recovery rate, and transmission rate. The R0 of the 2009 A/H1N1
inﬂuenza in the Republic of Korea is known as 1.6 (Suh et al., 2010;
Fraser et al., 2009; Nishiura et al., 2009; White et al., 2009). From our
mathematical model (1), the basic reproductive number is derived by
the next generation method (Diekmann et al., 1990) as follows:
⎧⎨⎩
⎫⎬⎭R β κ
qp
α
δ p
η
= * ϵ + + (1 − ) .0
(2)
The uncontrolled transmission rate, β*, can be calculated using the
given values of the parameters in (2).
2.3. Mathematical model of 2009 A/H1N1 inﬂuenza
We have modiﬁed the mathematical model developed by Arino
et al. (2008) and Chowell et al. (2009) to describe the transmission
dynamics for the 2009 A/H1N1 inﬂuenza in the Republic of Korea. The
total population (N) is classiﬁed into eight subclasses: susceptible (S),
latent (E), symptomatic infectious (I), asymptomatic infectious (A),
recovered (R), ineﬀectively vaccinated (U), eﬀectively vaccinated but
still unprotected (V), and protected (P) individuals. A transition
diagram between epidemic groups is shown in Fig. 2.
The uncontrolled transmission rate, β*, in the model (1) is changed
to β. The parameter β is the controlled transmission rate that includes
the nonpharmaceutical intervention factor. The antiviral and vaccina-
tion factors are also considered in this model. The antiviral factor is
denoted by the parameter a. The parameters ν and e represent the
vaccination rate and eﬃcacy, respectively. Vaccinated individuals
progress to protected individuals at a rate of ω.
In this work, the Korean government's nonpharmaceutical inter-
vention policies for A/H1N1 inﬂuenza, such as securing a budget,
quarantine, and the campaign for personnel hygiene, are quantiﬁed
through a data-ﬁtting process. These nonpharmaceutical policies
adopted by the government reduced the transmission rate of inﬂuenza.
The estimated transmission rate, β, includes this reduction eﬀect, while
the antiviral factor and the vaccination rate directly indicate the eﬀect
of antiviral and vaccine intervention strategies.
The transmission model of the 2009 A/H1N1 inﬂuenza is then
governed by nonlinear diﬀerential equations as follows:
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where Λ E qI δA= ϵ + + .
Note that if the vaccination ν is not considered in the model, then
the terms U, V, and P will be eliminated in the system (3). In our
model, the antiviral factor is not included in Period 1 and vaccination is
Fig. 2. Flow chart of the 2009 A/H1N1 inﬂuenza model. Note that the antiviral factor is not included in Period 1 and vaccination is not considered in Period 1 and Period 2.
Table 2
Parameters with definitions and values.
Symbol Description Value References
β Transmission rate Data-fitted
δ Infectivity reduction
factor for
asymptomatic group
1/2 Arino et al. (2008), Longini
et al. (2004, 2005)
ϵ Infectivity reduction
factor for latent group
0 Arino et al. (2008), Longini
et al. (2004)
q Infectivity reduction
factor for infectious
group
1/2 Arino et al. (2008), Longini
et al. (2004)
κ Progression rate to
infectious group (1/
days)
1/1.9 Centers for Disease Control and
Prevention (2009), Lessler et al.
(2009), Longini et al. (2004)
p Fraction of latent
developing symptoms
2/3 Balcan et al. (2009), Carrat et al.
(2008)
α Recovery rate for
infectious group (1/
days)
1/6 Centers for Disease Control and
Prevention, 2009, Lessler et al.
(2009), Ling et al. (2010), Tuite
et al. (2010)
η Recovery rate for
asymptomatic group
(1/days)
1/6 Centers for Disease Control and
Prevention, 2009
a Antiviral factor Data-fitted
e Vaccine efficacy 0.8 Assumed
ν Vaccination factor Data-fitted
ω Progression rate to the
protected group (1/
days)
1/10 Chowell et al. (2009), Lee et al.
(2012)
R0 The basic reproductive
number
1.6 Suh et al. (2010),Fraser et al.
(2009), Nishiura et al. (2009),
White et al. (2009)
N Total population 49,182,038 Statistics Korea (2011)
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not considered in Period 1 and Period 2 according to government's
intervention strategies conducted in 2009. The parameter values are
listed in Table 2.
2.4. Parameter estimations
Epidemic parameters are classiﬁed into two categories: the ﬁrst
type includes those that describe characteristics of the disease, and the
second describes circumstantial eﬀects such as standards of living or
government policies. For example, the latent period, κ1/ , is a char-
acteristic of the virus itself. However, the transmission rate (β),
antiviral rate (a), and vaccination rate (ν) are inﬂuenced by social
circumstances. For instance, developed countries are equipped with the
infrastructure necessary to handle outbreaks and can aﬀord to conduct
the required intervention steps. On the other hand, developing
countries lack adequate health care facilities. In order to build a
reasonable model for a speciﬁc country, the parameters β, a, and ν
must be estimated based on the country's speciﬁc circumstances.
Various intervention strategies are quantiﬁed through a parameter
estimation process. This gives a baseline interpretation of the optimal
intervention strategies in Section 3. In our study, the parameters β, a,
and ν are estimated from the cumulative incidence curve of the model,
∫C t pκE τ dτ( ) = ( )t
t
0
, which is ﬁtted to the cumulative incidence data in
each period. The least squares ﬁtting, lsqcurveﬁt in the MATLAB
optimization tool box, is used to ﬁnd the best ﬁtted parameters. The
ﬁtted parameters are listed in Table 3. Fig. 3 displays the cumulative
cases (red square) and the ﬁtted curve (black solid), C(t), from April 27
to December 31, 2009. The zoomed graph for Period 1 and Period 2 is
depicted in the inset of Fig. 3.
There are two possible reasons why the transmission rate, β, was
increased from Period 1 to Period 3. One reason is that the fall
semester classes of elementary, middle, and high schools as well as
universities begin at the end of August. If we zoom in on the incidence
data in Period 2, it is clearly observed that the incidence data is
increased rapidly from the end of August (see Fig. 3). The close
contacts at school might be one of the main factors for the wide spread
of the inﬂuenza epidemic. Another possibility is that the incidence data
were overdetermined for Period 2 and Period 3 because the number of
antiviral prescriptions was used as the incidence data.
2.5. Bootstrap
The bootstrap method, which is a numerical technique for statistical
inference, is used to show how accurate estimators are as those of the
unknown parameters, β, a, and ν. The basic idea of the bootstrap
method is to use the information of resampling data from the observed
data. The three parameters are estimated by using the resampling data
generated from a Poisson distribution with the mean equal to the
observed data. We assume that the observed data are Poisson
distributed at a ﬁxed time. This procedure is repeated 1,000 times
and the means, standard deviations (S.D.), and 95% conﬁdence
intervals (CI) are calculated for each estimation. Fig. 4 shows the
distributions of bootstrapping estimations for β, a, and ν. The sub-
scripts of the parameters represent the time period. The means, S.D.,
and 95% CI are listed in Table 4. A comparison between the bootstrap
estimations and the ﬁtted parameters shows the reliability of our
estimated parameters.
3. Characteristics of optimal control
In this section, the characterization of optimal control problem is
derived through the optimal control theory (Lenhart and Workman,
2007). The controlled state system of the 2009 A/H1N1 inﬂuenza in
the Republic of Korea is described as follows:
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where Λ E qI δA= ϵ + + , and
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We consider the three time-dependent controls in the controlled
system (4). The control u t( )1 is a nonpharmaceutical control that
represents the government's eﬀorts to reduce the transmission rate.
It is also called the social distancing control. In this model, the time-
dependent control, u t( )1 , is considered during Period 1 to reduce the
uncontrolled transmission rate β* which is calculated from the basic
reproductive number in (2). By subtracting the data-ﬁtted transmission
rate (β = 0.52641 ) from the uncontrolled transmission rate
(β* = 0.5333), the government's eﬀort to decrease the transmission
rate is quantiﬁed as σ = 0.0069. This value is used as an upperbound of
the nonpharmaceutical control, u t( )1 . The nonpharmaceutical control
includes all policies that are not related to drugs. For example, the
quarantine, detection and isolation of infectious people, school clo-
sures, cancellation of public events, and campaigns for personnel
hygiene are included in u t( )1 . The time-dependent antiviral and vaccine
controls are denoted by u t( )2 and u t( )3 , respectively. The constant
Table 3
Parameters estimated by data-fitting.
Parameter Period 1 (April
27–August 19)
Period 2 (August
20–October 18)
Period 3 (October
19–December 31)
Transmission rate
(β)
0.5264 0.8729 2.6037
Antiviral rate (a) – 0.4008 0.7291
Vaccination rate (ν) – – 0.5684
Fig. 3. Cumulative incidence data (red square) and its data-ﬁtted curve (black solid) as a
function of time. The zoomed graph for Period 1 and Period 2 is shown in the inset of the
ﬁgure because of the scale diﬀerence. (For interpretation of the references to color in this
ﬁgure caption, the reader is referred to the web version of this paper.)
S. Kim et al. Journal of Theoretical Biology 412 (2017) 74–85
77
antiviral and vaccine factors in the model (3) are replaced by the
control functions, u t( )2 and u t( )3 , in model (4), respectively. In 2009,
the manufacture and approval of the vaccine for A/H1N1 inﬂuenza
took approximately 6 months (Lee et al., 2013a). Today, new vaccine
manufacturing processes, such as cell culture manufacturing and
vectored inﬂuenza vaccine, can accomplish vaccine control in less time
(Milián and Kamen, 2015). Thus, we will consider the early vaccination
strategies in this study. We adjust only the nonpharmaceutical control,
u t( )1 , during Period 1, while we use the antiviral control, u t( )2 , and
vaccine control, u t( )3 , during Period 2 and Period 3. Since the
nonpharmaceutical intervention strategy is challenging to achieve
and has high socio-economic cost, we did not apply additional
nonpharmaceutical intervention strategies during Period 2 and
Period 3.
Our goal is to minimize the number of infectious individuals and
the cost of implementing the control measures. The cost is taken to be a
nonlinear quadratic function. The objective functional to be minimized
is then represented by
∫J u u u I t B u t B u t B u t dt( , , ) = ( ) + 2 ( ) + 2 ( ) + 2 ( ) .t
t
1 2 3
1
1
2 2
2
2 3
3
2f
0
We seek to ﬁnd optimal controls, u*1 , u*2 , and u*3 , satisfying
J u u u J u u u u Ω i( *, *, *) = min{ ( , , ) | ∈ , = 1, 2, 3},i1 2 3 1 2 3
where Ω Ω Ω Ω= ∪ ∪1 2 3, and
Ω u u u L t t u t σ u t u t
Ω u u u L t t u t u t a u t
Ω u u u L t t u t u t a u t
= {( , , ) ∈ ( , ) |0 ≤ ( ) ≤ , ( ) = ( ) = 0},
= {( , , ) ∈ ( , ) | ( ) = 0, 0 ≤ ( ) ≤ , 0 ≤ ( ) ≤ 0. 05},
= {( , , ) ∈ ( , ) | ( ) = 0, 0 ≤ ( ) ≤ , 0 ≤ ( ) ≤ 0. 05}.f
1 1 2 3 1 0 1 1 2 3
2 1 2 3 1 1 2 1 2 2 3
3 1 2 3 1 2 1 2 3 3
The parameters t0, t1, and t2 indicate the initial times of Period 1,
Period 2, and Period 3, respectively. The ﬁnal time is denoted by tf. The
upperbounds of nonpharmaceutical and antiviral controls are assumed
as the corresponding constant control measures. The upperbound of
vaccine control is assumed as 0.05 which is less than ν3. Since we will
suggest the early vaccination strategy, we cannot use the vaccination
rate in Period 3, ν3, as the upperbound of vaccine control during Period
2 and Period 3. The weight constants, B B,1 2, and B3, balance the
infectious individuals and cost terms due to their size and importance.
These weight constants might be diﬀerent for diﬀerent countries or
scenarios. For simplicity, we choose the baseline weight constants as
B B B= = = 10, 0001 2 3 .
Pontryagin's Maximum Principle (Pontryagin, 1987) is used to
solve the optimality system. Characteristics of optimal control pro-
Fig. 4. Distributions of bootstrapping estimations for β, a, and ν. The subscripts of the
Table 4
Bootstrapping results.
Parameter Fitted value Mean S.D. 95% CI
β1 0.5264 0.5264 1.6092e−04 (0.5260, 0.5267)
β2 0.8729 0.8279 1.3342e−04 (0.8277, 0.8282)
β3 2.6037 2.6032 6.0839e−04 (2.6020, 2.6044)
a2 0.4008 0.4008 1.0944e−04 (0.4006, 0.4011)
a3 0.7291 0.7287 4.1427e−04 (0.7279, 0.7295)
ν3 0.5684 0.5678 5.9247e−04 (0.5667, 0.5690)
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blems, including adjoint system, transversality conditions, and optim-
ality equations, are derived in Appendix.
We shall now discuss the optimal control strategies with a limited
vaccination coverage. Even though our control functions (u t( )1 , u t( )2 ,
and u t( )3 ) have constant bounds at time t, there is no additional
limitation on the total amount of controls during the entire simulation
time. While the use of nonpharmaceutical control has no practical
limitation on a host population, implementing pharmaceutical control
such as vaccine or antiviral strategies depends on its amount reserved
by the government. Especially, it is important to consider a limited
vaccination coverage. In our study, the limited vaccination coverage is
considered as follows:
*∫ u t S tN dt( )
( ) = ,
t
t
3
f
1 (5)
where * represents the vaccination coverage. This type of constraint is
known as an isoperimetric constraint (Lenhart and Workman, 2007).
We introduce one more state variable z(t) to consider the isoperimetric
constraint and it is deﬁned as ∫z t u τ dτ( ) = ( )t
t S τ
N3
( )
1
. Hence, the
isoperimetric constraint (5) can be rewritten as follows:
*dz t
dt
u t S t
N
z t z t( ) = ( ) ( ) , with ( ) = 0 and ( ) = .f3 1
The optimality system with the isoperimetric constraint (5) is
discussed in Appendix. In the results section, we compare optimal
control strategies without constraint and one with the isoperimetric
constraint.
4. Numerical results
In this section, we ﬁrst investigate the real-time prediction of
infectious transmission during the early period by using the model (3)
without pharmaceutical factors (a ν= = 0). We next propose optimal
intervention strategies under various scenarios by using the optimal
control theory.
4.1. Real-time prediction of incidence
Mathematical modeling is a simple and useful tool for predicting an
infection spread, especially during the early period. Before the antiviral
drugs and vaccines are approved, only the nonpharmaceutical inter-
vention strategy is available to reduce the incidence. Thus, at the
beginning of an epidemic, it is important to estimate the transmission
rate and predict the number of patients. Fig. 5 displays ﬁve real-time
predictions of daily and cumulative incidence in the left and right
columns, respectively. In the ﬁve scenarios, the model (3) without
pharmaceutical factors (a ν= = 0) is used for data-ﬁtting during the
given period from the outbreak onset (April 27), and then the
estimated constants are used to predict infection progress in the
following two weeks. For each scenario, the red squares, black solid,
and blue dashed curves represent the data, ﬁtted model, and model
prediction, respectively. The dotted vertical line indicates the starting
Fig. 5. Real-time prediction of the 2009 A/H1N1 incidence in the ﬁve scenarios (a)–(e). The ﬁve prediction scenarios are considered every two weeks from 4 weeks to 12 weeks. The red
squares, black solid curves, and blue dashed curves represent the data, ﬁtted model and model prediction, respectively. The dotted vertical line indicates the starting time of prediction.
(For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this paper.)
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time of the prediction. The relative diﬀerence in the cumulative
incidence between the data and the prediction,
× 100cumulative incidence − model predictionmodel prediction , is shown as an arrow in the upper
right-hand corner in the right column frames.
As we observed in Fig. 5, the cumulative incidences (red squares)
are mostly less than the number predicted (blue dashed curves) except
in the ﬁrst scenario (a). The main reason might be the intensive
government intervention policies for the relatively small incidence size.
We expect that it induced the decrease of the estimate for β during the
early stage of the epidemic in scenarios (b)–(e). Note that the
diminishing scale of β is very small. In scenario (a), the amount of
data is too low for real-time prediction; the number of cumulative
incidence during the ﬁrst 4 weeks is only 10 individuals. During the
early period, before the number of infectious individuals became too
large, the Korean government conducted good quarantine strategies.
Fig. 6. Scenario 1 (early vaccination strategy). Optimal controls and the corresponding state variables are displayed as function of time in the top three and bottom eight frames,
respectively. The blue solid curves indicate optimal controls and the corresponding optimal state variables. The black dot-dashed curves show the state variables of data-ﬁtted model. It
shows early vaccination is critical to prevent the epidemic. (For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this paper.)
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For instance, there was 24-h emergency health care service in public
health centers starting June 12 (6 weeks after onset). These early
nonpharmaceutical intervention policies helped to decrease the num-
ber of incidences. Scenario (b) explored this feature; the relative
diﬀerence between data and prediction is −44.16%, which could be
due to the introduction of this policy. However, scenarios (c) and (d)
show relatively good real-time predictions. The shape and magnitude of
prediction curves ﬁt the data well. In scenario (e), after 12 weeks, the
national public health crisis phase increased from caution to alert. The
government introduced the treatment in this period, and then the
infectious patient could obtain a prescribed antiviral drug. This action
appears to lead to a decline of daily incidence.
4.2. Optimal control strategies
In this section, the optimal control theory is used to ﬁnd the most
eﬀective strategies to minimize the number of infectious individuals
while the costs for implementing the controls are kept low under the
diﬀerent scenarios. We especially focus on investigating the eﬀects of
starting time and amount of vaccine.
4.2.1. Scenario 1: Early vaccination strategy
Due to the improved manufacturing system of vaccine, we could
suggest the early vaccination strategy. Recall that we apply only
nonpharmaceutical control, u t( )1 , during Period 1, while we use
antiviral control, u t( )2 , and vaccine control, u t( )3 , during Period 2 and
Period 3. Note that the vaccine policy is applied only to Period 3 in the
model (3) (see also Table 3). The constant data-ﬁtted transmission
rates, β = 0.82792 and β = 2.60373 , are used in Period 2 and Period 3,
respectively.
Fig. 6 depicts the optimal controls and the corresponding state
variables in the top three and the bottom eight frames, respectively. In
the bottom eight frames, the state variables from the data-ﬁtted model
and optimal solution are represented by black dot-dashed and blue
solid curves, respectively. Note that the upperbounds of nonpharma-
ceutical and antiviral control are set as the corresponding estimated
parameters and the upperbound of vaccine control is assumed as 0.05.
During Period 1, the optimal nonpharmaceutical control, u t( )1 , is taken
as its maximum, σ, because only nonpharmaceutical intervention is
accessible. During Period 2 and Period 3, the antiviral control function,
u t( )2 , is used much less than the data-ﬁtted constant for antiviral use;
a2=0.4008 for Period 2 and a3=0.7294 for Period 3. Both antiviral and
vaccine control are used at their maximum for the beginning of the
control periods and the controls decreased as time passed. The usage of
antiviral control is increased slightly at the beginning of Period 3, since
the transmission rate in Period 3 is much higher than that in Period 2.
While antiviral control is used steadily during Period 2 and Period 3,
vaccine control is used at its maximum until 200 days and decreased
thereafter. Early vaccine control, u t( )3 , could reduce the number of
susceptible individuals from Period 2. The fewer the number of
individuals that are exposed and infected under the same transmission
rate, the less is the antiviral control used. Compared to the curves of
infectious individuals in 2009 (black dot-dashed line), the peak of
infectious individuals has almost disappeared in the optimally con-
trolled case. Fig. 6 shows that the optimal control strategy of early
vaccination works well to eliminate the inﬂuenza epidemic. It suggests
that vaccine control is more meaningful if implemented earlier.
4.2.2. Scenario 2: Limited early vaccination strategies
In reality, there exists a limited amount of vaccines. In this section,
the isoperimetric constraint is used to reﬂect the vaccine limitation.
Furthermore, the starting day of vaccination is important as well as the
total vaccine usages. We investigated the impact of the vaccination
coverages and timing of using optimal vaccine strategies. All three
optimal controls are applied under the same conditions as in Scenario 1
except that the amount of vaccine is limited.
Fig. 7 depicts a contour map of the cumulative incidences on a log-
10 scale under the optimal control strategies as a function of vaccina-
tion coverage and timing. The black thick curve indicates the cumula-
tive incidence of the 2009 A/H1N1 inﬂuenza. We found that the
cumulative incidence signiﬁcantly decreases if the vaccination control
with the higher vaccination coverage is implemented earlier. Given a
ﬁxed number of cumulative cases to be achieved the sooner vaccination
begins the fewer individuals need to be vaccinated. If vaccination
control starts 115 days after the outbreak, about 62% vaccination
coverage is needed for the cumulative incidence in 2009. Even though
the vaccination coverage is over 85%, the cumulative incidence cannot
be reduced as much as the default one (black solid curve) when the
vaccination timing is signiﬁcantly delayed as in the case of a delay of
155 days. This implies that if the vaccination control is implemented
earlier, the impact of an inﬂuenza epidemic can be mitigated with less
vaccination coverage. If the vaccination coverage is increased from 60%
to 65%, the cumulative incidence considerably increases. On the other
hand, if the vaccination coverage is increased from 85% to 90%, the
Fig. 7. Scenario 2 (limited early vaccination strategy). A contour map of the cumulative incidences on a log-10 scale under the optimal control strategies as a function of vaccination
coverage and timing. The black thick curve indicates the cumulative incidence in 2009.
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changes of the cumulative incidences are relatively small. This indi-
cates that the marginal eﬃciency of vaccine control is decreasing.
Fig. 8 shows 12 case studies from the contour map (Fig. 7). In
Fig. 8, the optimal antiviral control, optimal vaccine controls, and the
corresponding cumulative incidences under diﬀerent vaccination cov-
erages and timings are displayed in the left, middle, and right columns,
respectively. The black solid, blue dotted, and red dot-dashed curves
indicate optimal solutions when vaccination starts at 115 days, 135
days, and 155 days after the outbreak onset, respectively. Four
vaccination coverages for the isoperimetric constraint,
* = 60%, 70%, 80%, and 90%, are considered. Note that the optimal
nonpharmaceutical controls are not displayed because these used at
their maximum during Period 1 for all cases. Fig. 8 shows that early
vaccine control leads to a signiﬁcant decrease of cumulative incidence
in spite of low vaccination coverage. If the amount of available vaccine
is reduced from the top to bottom frames, the antiviral controls are
used to a greater extent. These indicate that early vaccination plays a
signiﬁcant role and antiviral therapy is most important when the
vaccination rate is low.
5. Conclusions
A dynamic transmission model for the 2009 A/H1N1 inﬂuenza
epidemic in the Republic of Korea based on incidence data reported by
KCDC was developed in this work. The model was constructed for three
consecutive periods from April 27 to December 31, 2009. Since the
data included the eﬀects of interventions conducted by the Korean
government in 2009, we estimated the relative reduction of transmis-
sion rate, σ, by subtracting data-ﬁtted parameters from the uncon-
trolled transmission rate. In our study, this quantiﬁed reduced
transmission rate was used as the upperbound of the nonpharmaceu-
tical control during the early stage of outbreak (Period 1) in the study
of optimal control strategies. This is a new approach to suggest optimal
control strategies with the a realistic upperbound of control.
We investigated the real-time prediction of transmission during the
early epidemic period by using the model without pharmaceutical
factors. Surprisingly, the model made a relatively good real-time
prediction, especially in scenarios (c) and (d) (see Fig. 5), which show
predictions for the two week periods: 8 weeks and 10 weeks after the
onset. Fig. 5 also suggests that the Korean government did a good job
on the quarantine strategy during the early period before the amount of
infectious individuals became too large. We explored the SEIAR model
Fig. 8. Scenario 2 (limited early vaccination strategy). The impact of vaccination coverage on two optimal control measures (antiviral and vaccine controls) and the corresponding
cumulative incidences are explored under the three diﬀerent vaccine starting days. The black solid, blue dotted, red dot-dashed curves indicate optimal solutions by vaccination starting
115 days, 135 days, and 155 days after the outbreak onset, respectively. Four vaccination coverages for the isoperimetric constraint (* = 60%, 70%, 80%, 90%) are considered. (For
interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this paper.)
S. Kim et al. Journal of Theoretical Biology 412 (2017) 74–85
82
without considering the pharmaceutical intervention and provided a
qualitatively good prediction during the early stage of the epidemic.
Optimal control theory was applied to our model over the entire
period, which includes nonpharmaceutical, antiviral, and vaccine
policies. One very important factor in epidemic prevention is vaccina-
tion. We investigated the eﬀects of timing and vaccine coverage on the
cumulative incidence. Since new vaccine manufacturing systems could
provide vaccines in a time less than 6 months from the outbreak
(Milián and Kamen, 2015), we applied the vaccine strategy from 115
days after the onset in our study. The results showed that an early
optimal vaccine strategy is critical to eliminate the epidemic (see
Fig. 6). Further, the results show good agreement with the result of
previous studies on the beneﬁts of early vaccination and nonpharma-
ceutical intervention for the inﬂuenza A epidemic (Khazeni et al.,
2014). Since the amount of vaccine is limited in reality, we considered
the limited optimal vaccine strategy using the isoperimetric constraint.
Under the same vaccination coverage, the cumulative incidence
increased signiﬁcantly with delaying vaccination time. Even if the
vaccination coverage is high, the epidemic can occur when the
vaccination timing is too late (see Fig. 7). Our results imply that the
timing of vaccination is signiﬁcant to prevent the epidemic.
In our study, there remains some uncertainty because of data
inconsistency. After government policy changed, the test conﬁrming
PCR was not conducted on all ILI patients. Thus, seasonal ﬂu patients
might have been included in the 2009 A/H1N1 inﬂuenza incidence.
This indicates that the transmission rate might be overestimated.
Additionally, even though the vaccine data were also collected by the
government, it is diﬃcult to estimate the number of vaccinated
individuals in 2009 because the vaccination policy was changed
frequently. With more detailed data, vaccine control strategies could
be improved. Despite these limitations, this study gives some insight on
intervention strategies that could be used for new emerging infectious
diseases in the Republic of Korea.
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Appendix
From Pontryagin's Maximum Principle (Pontryagin, 1987), optimal controls should satisfy the necessary conditions. Pontryagin's Maximum
Principle changes (4) into problem that minimize pointwise a Hamiltonian H, with respect to the control.
∑ ∑H I t B u t λ g= ( ) + 2 ( ) + ,i
i
i
i
i i
=1
3
2
=1
8
(6)
where gi is the right hand side of the diﬀerential equation of the ith state variable. Applying Pontryagin's Maximum Principle, we obtain
Theorem 1. There exist optimal controls u t*( )1 , u t*( )2 , and u t*( )3 minimizing the objective functional J u t u t u t( ( ), ( ), ( ))1 2 3 over Ω Ω Ω Ω= ∪ ∪1 2 3,
where
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= {( , , ) ∈ ( , ) | ( ) = 0, 0 ≤ ( ) ≤ , 0 ≤ ( ) ≤ 0. 05}.f
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Given these optimal solutions, there exist adjoint variables, λ t λ t( ),…, ( )1 8 , which satisfy
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with transversality conditions λ t( ) = 0i f , for i = 1,…,8.
Furthermore,
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where u t( )max1 , u t( )max2 , u t( )max3 indicate the period-dependent upperbounds of control.
Proof. The existence of optimal controls u t*( )1 , u t*( )2 , and u t*( )3 such that J u t u t u t u t u t u t( *( ), *( ), *( )) = min ( ( ), ( ), ( ))Ω1 2 3 1 2 3 with state system (4) is
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given by the convexity of the objective functional integrand. By using Pontryagin's Maximum Principle (Pontryagin, 1987), the adjoint equations
and transversality conditions are obtained. Diﬀerentiation of Hamiltonian H with respect to the state variable gives the following system:
= − , = − , = − , = − ,
= − , = − , = − , = − ,
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dt
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with λ t( ) = 0i f for i = 1,…,8.
Optimal controls u t*( )1 , u t*( )2 , and u t*( )3 are derived using the following optimality conditions:
B u λ λ S λ λ U λ λ V
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at u t*( )1 , u t*( )2 , and u t*( )3 on the set (7). On this set
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Taking into account the bounds on controls, we obtain the characterization of u t*( )1 , u t*( )2 , and u t*( )3 in (8).□
The forward–backward sweep method is used to solve the optimality system with the initial conditions for the state variables and the
transversality conditions for the adjoint system. The state equations are solved forward in time and the adjoint system is solved backward in time
with initial guesses of control functions. The controls are updated using a convex combination of the previous controls and the optimality equations
from the current state and adjoint variables. The iteration is repeated until convergence occurs (Lenhart and Workman, 2007).
For Scenario 2 (limited early vaccination strategy), the 9th state variable from the isoperimetric constraint, z(t), is added, and the HamiltonianH
is changed as follows:
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With the same process of Theorem 1, z(t), we have one more adjoint equation,
dλ
dt
H
z
= −∂
∂
.9
Then, the optimal control u t*( )3 is changed as follows:
⎛
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⎠⎟u t λ λ e λ e
λ
N
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*( ) = − (1 − ) − − .3 1 6 7 9
3
In this problem, there is one state variable with the additional ﬁxed endpoint ( *z t( ) =f ) to consider the isoperimetric constraint which results in
the loss of the terminal condition for the corresponding adjoint variable. The adapted forward–backward sweep method with the multiplier of the
integrand of the objective functional, λ0, equal to 1 is used in our study. The main idea of the adapted forward–backward sweep method is to guess a
value for the missing terminal condition and use a root ﬁnding method to converge an appropriate value to satisfy the ﬁxed-end condition of an
artiﬁcial state variable. Thus, by using this algorithm, we could ﬁnd optimal controls satisfying the new necessary conditions which involve with not
a ﬁxed terminal condition for the adjoint variable, but the ﬁxed endpoint of the state variable.
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